title: The Cost-Effectiveness Of Dabigatran Etexilate Compared With Rivaroxaban In The Treatment Of Acute Venous Thromboembolism In The Uk.
authors.affiliation: IMS Health HEOR, Vilvoorde, Belgium.
authors.forename: A V
authors.initials: AV
authors.lastname: Jugrin
authors.affiliation: Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany.
authors.forename: A V
authors.initials: AV
authors.lastname: Ustyugova
authors.affiliation: Boehringer Ingelheim Ltd, Bracknell, UK.
authors.forename: M
authors.initials: M
authors.lastname: Urbich
authors.affiliation: IMS Health HEOR, Vilvoorde, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Lamotte
authors.affiliation: Boehringer Ingelheim, Berkshire, UK.
authors.forename: T J
authors.initials: TJ
authors.lastname: Sunderland